Individual differences in prothrombin time-international normalized ratio variation following coadministration of the anticancer agents S-1 and warfarin: 3 case reports.

Yamamuro, F; Miki, A; Kondo, G; Maeda, T; Satoh, H; Hori, S; Sawada, Y

Yamamuro, F; Miki, A; Kondo, G; Maeda, T; Satoh, H; Hori, S; Sawada, Y.

Affiliation

Yamamuro F; Department of Pharmacy Kumamoto City Hospital, The University of Tokyo, Japan.

Int J Clin Pharmacol Ther ; 49(11): 700-4, 2011 Nov.

Article in En | MEDLINE | ID: mdl-22011696

Subject(s)

Anticoagulants/pharmacology; Antimetabolites, Antineoplastic/pharmacology; International Normalized Ratio; Oxonic Acid/pharmacology; Prothrombin Time; Tegafur/pharmacology; Warfarin/pharmacology; Aged; Drug Combinations; Drug Interactions; Female; Humans; Male; Middle Aged

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Prothrombin Time / Warfarin / Tegafur / International Normalized Ratio / Anticoagulants / Antimetabolites, Antineoplastic Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Clin Pharmacol Ther Year: 2011 Document type: Article

Search on Google

XML

PubMed Links